Company intelligence / Profile preview

In Vitro Technologies

Noble Park North, Victoria, Australiainvitro.com.au ↗

Ownership: Private
Development stage: Other

Overview

In Vitro Technologies supplies laboratory equipment, consumables, reagents, cells, and infection control solutions to support research in cancer, neuroscience, immunology, diabetes & obesity, cardiology, pharmacology and drug discovery. The company partners with global suppliers to provide high-quality products for life science research in Australia and New Zealand. The US entity provides in vitro testing services for pharmaceutical/biotech/chemical R&D.

Industry: Drug Discovery Services

Partnerships

Partners with world-class suppliers of laboratory equipment/reagents globally (specific names not listed)

Beyond the preview

Go deeper on In Vitro Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on In Vitro Technologies.

Explore the full profile